Back to search

Article

Elexacaftor/Tezacaftor/Ivacaftor alters branching morphogenesis of the mouse embryonic lung

2021-11-04

Abstract excerpt

<h4>Introduction</h4> CFTR modulators triple combo-therapy Elexacaftor/Tezacaftor/Ivacaftor (ETI) has proven to clinically benefit homozygous and heterozygous F508del patients. As a result, an increasing number of pregnancies is expected. Studies of the potential impact of these modulators on the development of the foetus are mandatory. <h4>Materials</h4> We used the early mouse embryonic lung organ culture mode...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d283c23f-0181-5998-be67-5257eb611486
DOI
10.1101/2021.11.01.466814
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Elexacaftor/Tezacaftor/Ivacaftor alters branching morphogenesis of the mouse embryonic lungDOI 10.1101/2021.11.01.466814
Select a neighboring publication to make it the new centre.